Programme and Presentations
UK & Ireland Prostate Brachytherapy Conference 2026
Tips and Tricks in Brachytherapy
Watford Football Club, Vicarage Road Stadium, Watford
| Agenda | Video | Presenter/s | |
| 08:30 | Welcome & Opening – the history of Mount Vernon Cancer Centre | Peter Hoskin & Andreas Makris Mount Vernon Cancer Centre | |
| Invited Speakers | Chairs: Mohammed Abdul‑Latif, Thomas Hague & Dan Meigas | ||
| 09:00 | Tips and Tricks – Physician’s perspective |
|
Roberto Alonzi Mount Vernon Cancer Centre |
| 09:25 |
Tips and Tricks – Physicist’s perspective. Sharper Plans and Greener Practice – optimiser tips & seeking long-term sustainability in Brachytherapy |
|
George Kirby & Gerry Lowe Mount Vernon Cancer Centre |
| 09:50 | Tips and Tricks – Radiographer’s perspective |
|
RTT Team Mount Vernon Cancer Centre |
| 10:20 | One-minute Poster Pitches |
|
|
| 10:45 | Tea & Coffee/Exhibition and Poster Viewing | ||
| 11.15 | Prostate Guideway – Redefining confidence in the Interventional Suite |
|
Elekta |
| Proffered Presentation | Chairs: Peter Hoskin & Gerry Lowe | ||
| 11:25 | Work of the National HDR Prostate Proknow Group |
|
Katie McHugh Southend Hospital |
| 11.35 |
Implementation of an altitude correction factor for low-energy brachytherapy seed measurements |
|
Joe Hobson Royal Surrey Cancer Centre |
| 11.45 |
Commissioning of a micro-silica bead TLD system for in vivo dosimetry and clinical feasibility study in patient undergoing prostate brachytherapy |
|
Will Hamblyn & Amani Chowdhury Mount Vernon Cancer Centre |
| 11.55 |
Dosimetric impact of a rectal spacer in HDR prostate brachytherapy: A retrospective paired analysis |
|
Samuel Worster Norfolk and Norwich University Hospital |
| 12:05 |
HDR brachytherapy boost with external beam radiotherapy for high-risk node-negative localised prostate cancer: long-term outcomes without systemic intensification & HDR brachytherapy boost with EBRT for localised prostate cancer: long-term outcomes and toxicity in predominately high-risk patients. |
|
Mahbuba Choudhury Southend Hospital |
| 12:15 | Lunch/Exhibition and Poster Viewing | ||
| Debate | |||
| 13:15 | Debate – “This House believes that brachytherapy provision should be centralised” |
|
Mohammed Abdul‑Latif (Mount Vernon Cancer Centre) & Ann Henry (Leeds Teaching Hospital) |
| Proffered Presentations | Chairs: Amani Chowdhury & Dalia Haider | ||
| 14:00 | MR Fusion, AI contoured target boost prosate brachytherapy for LDR and Alpha DaRT therapy |
|
Diane Whitney Cambridge University Hospital |
| 14:10 |
Single Institute Audit of HDR Brachytherapy as Monotherapy (27Gy in 2 fractions) for Localised Prostate Cancer |
|
Alexander Cain Mid & South Essex Hosptials |
| 14:20 | Focal salvage HDR brachytherapy for locally recurrent prostate cancer |
|
Emma Bennion-Pedley St James’ University Hospital |
| 14:30 |
Salvage HDR brachytherapy for isolated seminal vesicle recurrence following definitive treatment for prostate cancer |
|
Tracy Lim Mount Vernon Cancer Centre |
| 14:40 |
The LDR BURST Trial: Comparing the side effects of LDR Brachytherapy against Ultra-hypofractionated Radiotherapy using Spacer gel Treatment |
|
William Hayhurst Royal Surrey County Hospital |
| Invited Speakers | Chairs: Roberto Alonzi & Tracy Lim | ||
| 14:50 |
Palladium-103 in LDR Prostate Brachytherapy: Dosimetric Advantages and the Path to Focal Treatment |
|
Peter F. Orio Dana Faber Cancer Institute |
| 15:50 | Tea & Coffee/Exhibition and Poster Viewing | ||
| 16:20 | Prostate brachytherapy – An international perspective |
|
Hathal Haddad University of Tübingen |
| 16:50 | Theatrical Trials and Tribulations |
|
Albert Edwards Kent Oncology Centre |
| 17:20 | Meeting Close and Handover | Roberto Alonzi |
| Poster Pitches | Poster | Author/s | |
| Assessment of Delivered Versus Planned D90 Ratios in LDR Prostate Brachytherapy |
|
Chris Wood Edinburgh Cancer Centre | |
|
Factors Influencing Overnight Hospital Stay Following LDR Prostate Brachytherapy: A Retrospective Study |
|
Hanna Mahmood Mount Vernon Cancer Centre | |
| A review of infection outcomes following HDR prostate brachytherapy at a single centre |
|
Emma Stallard Mount Vernon Cancer Centre | |
|
Multi-Site Internal In-Vivo Dose Verification in HDR Prostate Brachytherapy: Clinical Implementation of a Novel Dosimetry System |
|
Fatemeh Nazari TRUEInvivo | |
| Patient experience of HDR Prostate Brachytherapy at Mount Vernon Cancer Centre (RTT) |
|
Kerry Chapman Mount Vernon Cancer Centre | |
|
Service Evaluation of Corrective Action in HDR Prostate Brachytherapy: Establishing Tolerance Thresholds Following a Near Miss Incident |
|
Thomas Hague Mount Vernon Cancer Centre | |
|
Plan2Plan – Using ESAPI to Automate the Plan-Checking of Copied Brachytherapy Plans (Physics) |
|
George Kirby Mount Vernon Cancer Centre | |
| Utilisation of LDR Seeds using 4D Brachytherapy Technique |
|
Matthew Bolt Royal Surrey Cancer Centre | |
| Review of a New Dosimetry System in LDR Brachytherapy |
|
Emma Doran Beatson West of Scotland Cancer Centre | |
|
Improving ergonomics and standardization of free needle length measurement in prostate HDR brachytherapy |
|
Tomasz Kostecki University of Silesia, Katowice | |
|
Patient Reported Outcomes and Dosimetric Impact of Hydrogel Rectal Spacers in Prostate Radiotherapy |
|
Sara Hodgkinson Kent Oncology Centre |